Data: Two addresses suspected of maliciously dumping RVV for over $6.18 million
According to ChainCatcher, on-chain analyst @ai_9684xtpa has monitored that the Alpha token RVV experienced an abnormal plunge after its launch. On-chain data shows that related stakeholders are suspected of maliciously dumping tokens through compromised accounts, profiting at least $9.09 million.
The event timeline shows: After RVV was listed on a certain exchange Alpha, the contract was activated; the project's multi-signature address transferred 800 million tokens to 8 multi-signature accounts. These accounts began distributing tokens to dozens of new addresses and gradually selling them off. Among them, addresses 0x9E6...A0b3e and 0x643...8178C cashed out over $6.18 million in total, with the former conducting multiple trades via 1inch and the latter selling through Zerion. The project team has confirmed that a third-party market-making account was compromised and is currently cooperating to track and handle the related losses.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.
TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).
